| ID | 352 |
|---|
| No | 352 |
|---|
| Brand Name | LORLACARE |
|---|
| Ingredients | LORLATINIB 100 MG |
|---|
| Dosage Form | CAPSULE |
|---|
| Primary Packaging | BOTTLE |
|---|
| Storage | STORE BELOW 30C |
|---|
| Shelf Life | 3 YEARS |
|---|
| Pack Size | BOX OF 30'S |
|---|
| Dispensing Category | Prescription only |
|---|
| ATC Classification | - |
|---|
| Pharmaceutical Class | ANTINEOPLASTIC |
|---|
| Indications | FOR THE TREATMENT OF PATIENTS WITH ANAPLASTIC LYMPHOMA KINASE-POSITIVE METASTATIC NON - SMALL CELL LUNG CANCER WHOSE DISEASE HAS PROGRESSED ON CRIZOTINIB AND AT LEAST ONE OTHER ALK INHIBITOR FOR METASTATIC DISEASE OR ALECTINIB AS THE FIRST ALK INHIBITOR THERAPY FOR METASTATIC OR CRITINIB AS THE FIRST ALK INHIBITOR THERAPY METASTATIC DISEASE |
|---|
| Contraindications | IN PATIENTS TAKING STRONG CYP3A INDUCERS, DUE TO THE POTENTIAL FOR SERIOUS HEPATOTOXICITY |
|---|
| Side Effects | CNS EFFECT, INTERSTITIAL LUNG DISEASE/PNEUMONITIS, HYPERLIPIDEMIA ATRIVENTRICULAR BLOCK |
|---|
| Unit Price | |
|---|
| EDL |
No |
|---|
| Description | CAPSULE CONTAINS WHITE POWDER |
|---|
| Note | |
|---|
| License Owner | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Manufacturer | BOTEN ELEMENTO PHARMA FACTORY |
|---|
| Country | LAO PDR |
|---|
| Import Registration No | |
|---|
| Import Registration Date | |
|---|
| Activity | CERTIFICATE RELEASED |
|---|
| Applied Date | - |
|---|
| FDD Registration No | 03 L 0849/21 |
|---|
| FDD Registration Date | 2024-08-07 |
|---|
| Expiry Date | 2027-08-06 |
|---|
